---
title: "Elanco Animal Health Incorporated Stock 12‑Month Price Target Raised to $30.23, Implies 19% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293465323.md"
description: "Elanco Animal Health's 12-month average price target was raised to $30.23 by 13 analysts, up from $30, implying a 19% upside based on the July 21 closing price. The consensus rating remains 'Buy' across 18 covering analysts, with 16 buys, 2 holds, and no sells."
datetime: "2026-07-22T11:20:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293465323.md)
  - [en](https://longbridge.com/en/news/293465323.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293465323.md)
generator: "portal-rs"
---

# Elanco Animal Health Incorporated Stock 12‑Month Price Target Raised to $30.23, Implies 19% Upside

-   According to estimates from 13 analysts, Elanco Animal Health Incorporated stock's average price target has risen from $30 to $30.23, with forecasts ranging from $26 to $32 per share
-   Based on the Jul. 21 closing price, the updated target implies approximately 19% potential upside
-   Consensus rating remains at “Buy” across 18 covering analysts, with 16 Buys, 2 Holds and 0 Sells

Explore more price target data and ratings for Elanco Animal Health Incorporated on the , and track all previous and future analyst recommendations for Elanco Animal Health Incorporated in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [ELAN.US](https://longbridge.com/en/quote/ELAN.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Top Executive Quietly Boosts Stake in Elanco Animal Health](https://longbridge.com/en/news/296293784.md)
- [Elanco Animal Health (ELAN) Lifted Guidance, Is The 21% Discount Still There?](https://longbridge.com/en/news/296298826.md)
- [Elanco director Lawrence Kurzius acquires 40,000 common shares for $935,920](https://longbridge.com/en/news/296649591.md)
- [Elanco GC, Corporate Secretary Shiv O’Neill buys 3,998 common shares for $94,278.84](https://longbridge.com/en/news/296267436.md)
- [Barclays Sticks to Its Buy Rating for Elanco Animal Health (ELAN)](https://longbridge.com/en/news/296759200.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**